SORLA regulates endosomal trafficking and oncogenic fitness of HER2 (Q64289807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

title

SORLA regulates endosomal trafficking and oncogenic fitness of HER2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Ilkka Paatero

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Elisa Närvä

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Maria Georgiadou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Harri Sihto

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Heikki Joensuu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Johanna Ivaska

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

1

Mika Pietilä

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

17

Pekka Taimen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Pranshu Sahgal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Niklas Z Jäntti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Hussein Al-Akhrass

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Johanna Lilja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Olav M Andersen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Artur Padzik

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Matias Blomqvist

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Irena Saarinen

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

Peter J Boström

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

language of work or name

English

0 references

publication date

28 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

2340

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

describes a project that uses

29 April 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6538630/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Activating HER2 mutations in HER2 gene amplification negative breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Endosomal dynamics of Met determine signaling output

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Tensin-4-Dependent MET Stabilization Is Essential for Survival and Proliferation in Carcinoma Cells.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Threshold-controlled ubiquitination of the EGFR directs receptor fate

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The Mysterious Ways of ErbB2/HER2 Trafficking

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Identification of the domain in ErbB2 that restricts ligand-induced degradation

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Endocytosis and signalling: intertwining molecular networks

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Association with membrane protrusions makes ErbB2 an internalization-resistant receptor

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Geldanamycin-induced down-regulation of ErbB2 from the plasma membrane is clathrin dependent but proteasomal activity independent

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

SorLA is a molecular link for retromer-dependent sorting of the Amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

SorLA regulates the activity of lipoprotein lipase by intracellular trafficking

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Interaction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Assays to assess autophagy induction and fusion of autophagic vacuoles with a degradative compartment, using monodansylcadaverine (MDC) and DQ-BSA.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

HER2 expression status in diverse cancers: review of results from 37,992 patients

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The retromer complex - endosomal protein recycling and beyond

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1).

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

The HSP90 inhibitor geldanamycin perturbs endosomal structure and drives recycling ErbB2 and transferrin to modified MVBs/lysosomal compartments

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Transformation of rat cells by DNA of human adenovirus 5

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Distinct recycling of active and inactive β1 integrins

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

PDGF-regulated rab4-dependent recycling of alphavbeta3 integrin from early endosomes is necessary for cell adhesion and spreading

1 reference

https://api.crossref.org/works/10.1038/S41467-019-10275-0

7 January 2021

Identification of ErbB-2 kinase domain motifs required for geldanamycin-induced degradation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31138794

12 December 2020

inferred from PubMed ID database lookup

Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/31138794

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/S41467-019-10275-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31138794 AND SRC:MED&resulttype=core&format=json

29 April 2020

PubMed publication ID

31138794

1 reference